The 2026 Healthtech Messaging Index
Avenda Health
avendahealth.com·scored August 23, 2026
25/38
Approaching
Close. The bones are good. A few targeted fixes on the weakest signals would push Avenda Health into magnetic territory.
The page we scored
The AI Recommendation Check
When we asked AI who to recommend for AI-powered prostate cancer diagnostic and treatment planning software, it named:
Buyer we put in the prompt: Urologist or prostate cancer specialist (physician) making treatment planning decisions, or a newly diagnosed prostate cancer patient researching their options. Both the buyer and the category were inferred from Avenda Health’s homepage alone. The model had no web access.
Avenda Health was on the list.
AI named them for their own category. That's the signal every homepage is supposed to send.
AI named you when asked who it recommends for "AI-powered prostate cancer diagnostic and treatment planning software", and described you accurately: "Avenda Health develops AI-based software that creates 3D cancer mapping models from patient biopsy and imaging data to help guide prostate cancer treatment planning.". Your positioning is landing with the machines.
Overall assessment
Avenda Health's biggest strength is its concrete, cited clinical evidence ... specific percentages, peer-reviewed journal references, and FDA-cleared AI claims give it rare credibility in a space full of vague health tech promises. The biggest gap is the complete absence of social proof and a muddled dual-audience problem: the page never commits to one ICP (patient or physician), has no testimonials or named users, and provides no numbered path that guides either audience to a clear next step.
Signal by category
Narrative Clarity
8 signals
Trust Signal
4 signals
AI Signal
6 signals
Conversion Signal
1 signal
Weakest signal · fix this first
10Social Proof
“No customer names, testimonials with names/titles, named case studies, or patient/physician video stories anywhere on the page.”
The page has zero social proof ... no physician quotes, no patient stories, no logos of health systems or partners using Unfold AI.
All 19 signals, scored 0 to 2.
Total 25/38
Narrative Clarity
8 signals
- 1
01The 7-Second Test
“Bringing Confidence to your Prostate Cancer Treatment Decisions”
The hero communicates a general topic (prostate cancer decisions) but the POV, who specifically it's for (patients vs. doctors), and what exactly Unfold AI does are not instantly clear in 7 seconds above the fold.
- 1
02Rebellion / Movement
“Treating the entire prostate, without Unfold AI, leads to urinary and sexual dysfunction in more than 50% of patients.”
There is an implicit enemy (treating blindly without cancer mapping), but no named status quo, named industry pattern, or explicit rebellion framing ... it's statistical, not a manifesto.
- 2
03Owned Language & Category
“Unfold AI generates a heatmap or Cancer Estimation Map (CEM) that visualizes where the cancer is in 3D”
Avenda owns clearly named proprietary terms ... 'Unfold AI,' 'Cancer Estimation Map (CEM)' ... that are specific enough for an AI to cite and attribute uniquely to this company.
- 1
04ICP Clarity
“Patients should not have to choose between treating their prostate cancer and maintaining their quality of life.”
The page addresses both patients and physicians but never explicitly names either as the primary ICP with role, setting, or company context ... it switches audiences without declaring one.
- 2
05Problem Leadership
“Prostate Cancer Diagnosis and Treatment is Hard to Navigate”
The page leads with the patient/physician problem ... navigating prostate cancer treatment ... before introducing the solution, using real consequence statistics to frame the stakes.
- 2
06Solution Clarity
“Unfold AI precisely maps prostate cancer leading to better treatment decisions.”
This single sentence clearly explains what the product does and why it matters ... a visitor can repeat it verbatim after reading the page.
- 2
07Cost of Inaction
“Treating focally, without Unfold AI leads to 24-49% of patients having residual cancer.”
The page explicitly names the clinical and quality-of-life price of inaction with specific cited percentages, making the cost of not acting concrete and credible.
- 1
08Promised Land
“Patients treated with Unfold AI margins are 71% more likely to be cancer-free.”
There is a promised outcome (cancer-free) backed by a stat, but the page never paints a vivid 'after' life ... no narrative of what a treated, confident, quality-of-life-preserved patient actually looks like.
Trust Signal
4 signals
- 2
09Proof & Evidence
“Patients treated with Unfold AI margins are 71% more likely to be cancer-free.[3]”
The page provides specific percentages with peer-reviewed citations (Journal of Urology, BJU Int.), which are concrete, sourced outcomes rather than marketing adjectives.
- 0
10Social Proofweakest
“No customer names, testimonials with names/titles, named case studies, or patient/physician video stories anywhere on the page.”
The page has zero social proof ... no physician quotes, no patient stories, no logos of health systems or partners using Unfold AI.
- 1
11Authority & Credibility
“based on 100,000's of patient data points gathered over 10-years of research and validated in multiple clinical studies”
Research depth and FDA clearance are mentioned but no founder credentials, named researchers, awards, or institutional affiliations are surfaced to establish personal authority.
- 0
12Alternatives Acknowledged
“No mention of MRI alone, competitors, active surveillance without tools, or 'do nothing' as a named alternative anywhere on the page.”
The page never acknowledges what buyers might do instead of Unfold AI, missing the opportunity to differentiate against MRI-only approaches or competing diagnostic tools by name.
AI Signal
6 signals
- 1
13Customer Focus
“Patients should not have to choose between treating their prostate cancer and maintaining their quality of life.”
The page gives lip service to the patient's transformation but spends most of its space on the product's capabilities and clinical statistics, making the company the protagonist more than the customer.
- 2
14AI-Parmesan Index
“Our proprietary artificial intelligence algorithms used to analyze prostate cancer are FDA-cleared.”
AI claims are mechanistic and specific ... FDA-cleared algorithms, Cancer Estimation Map generation from MRI/biopsy/pathology/PSA data ... not vague 'AI-powered' sprinkle language.
- 2
15LLM Quotability
“Unfold AI precisely maps prostate cancer leading to better treatment decisions.”
Several declarative, citation-ready sentences exist on the page that an LLM could lift verbatim, including the 71% cancer-free stat tied to a named journal publication.
- 0
16Copyright Freshness
“No visible dates on blog posts, case studies, or content; no copyright year visible in the scraped content.”
The page shows no recency signals ... no dated publications, blog posts, or copyright year ... so AI engines cannot assess freshness of content.
- 2
17Entity Distinctiveness
“Cancer Estimation Map (CEM) that visualizes where the cancer is in 3D, significantly outperforming MRI's ability”
The named product, owned terminology (CEM, Unfold AI), specific clinical claim against MRI, and FDA clearance combine to make this company unmistakably distinct from generic prostate cancer diagnostic competitors.
- 2
18AI Recommendation Check
“AI described you as: "Avenda Health develops AI-based software that creates 3D cancer mapping models from patient biopsy and imaging data to help guide prostate cancer treatment planning.”
AI named you when asked who it recommends for "AI-powered prostate cancer diagnostic and treatment planning software", and described you accurately: "Avenda Health develops AI-based software that creates 3D cancer mapping models from patient biopsy and imaging data to help guide prostate cancer treatment planning.". Your positioning is landing with the machines.
Conversion Signal
1 signal
- 1
19Path & CTA Clarity
“TALK TO AN AVENDA HEALTH PATIENT EDUCATION SPECIALIST" / "FIND AN UNFOLD AI DOCTOR”
There are two CTAs present but no numbered process tying them together, and it's unclear which is primary ... the page lacks a clear sequential path that connects steps to a single dominant action.
Keep the lead
AI already names Avenda Health. The next edition decides if it still does.
Twenty minutes with Greg. Bring the page, bring the argument. You’ll leave knowing exactly which signal is costing Avenda Health the AI recommendation, and what to write instead.
Not on the list? Run your homepage through the free Brand Signal Score and see where you’d land. Same 19 signals, same AI check, two minutes.